Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Manipal Health raises...

    Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

    Written by Ruby Khatun Khatun Published On 2018-04-11T09:44:34+05:30  |  Updated On 16 Aug 2021 3:57 PM IST
    Manipal Health raises offer for Fortis Healthcare- Firm now valued at Rs 6,061 crore

    New Delhi: Manipal Health Enterprises raised its offer for Fortis Healthcare Ltd by valuing the hospital business higher at Rs 6,061 crore, according to a regulatory filing.


    The latest move comes amid concerns raised by various FHL shareholders about the valuation of the hospital business.


    In an unsolicited offer, Manipal Health said it "proposes to offer an upward revision of Rs 1,058 crore to the shareholders of FHL over and above hospital business of FHL's equity valuation of Rs 5,003 crore".


    This would result in an equity value of Rs 6,061 crore being attributed to the hospital business of FHL, which would result in a "more favourable share exchange ratio for shareholders of FHL", Manipal Health said in the letter to FHL.


    The letter, which has been submitted to stock exchanges by FHL, also said that Manipal Health would look at a rights issue worth up to Rs 4,000 crore after completion of the demerger. The rights issue was not in the original offer.


    As per the offer, Manipal Health would not purchase any equity shares from FHL and SRL would continue to be a subsidiary of the latter.


    The original proposal had envisaged purchase of 1.59 crore or 20 percent stake of SRL for a consideration of around Rs 720 crore.


    Last month, FHL board approved the demerger of Fortis hospitals business, which would be acquired by Manipal Hospitals and TPG Capital, along with the sale of 20 percent stake in diagnostics chain SRL Ltd. Ranjan Pai and TPG would invest Rs 3,900 crore into Manipal Hospitals.


    "FHL shall not be entitled to accept the revised proposals piece-meal and rejection/ non-acceptance by FHL of any of the revised proposals shall be considered a rejection of the all the revised proposals," the letter said.

    FHLFortisFortis HealthcareHospital BusinessManipalManipal HealthManipal Health EnterprisesManipal HospitalsOfferRanjan PaiSRL DiagnosticssweetensTPG capitalvaluation
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok